Aquaporin's Trading Statement for Q1 2025
Company Announcement
No. 08/2025
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
KONGENS LYNGBY, Denmark — Aquaporin A/S (CSE: AQP), a pioneering water technology company focused on innovative water filtration through biotechnology, announces its Q1 2025 Trading Statement covering January 1 to March 31, 2025.
"As we progress in 2025, we anticipate returning to our growth trajectory as we focus on achieving profitability. We are observing a resurgence in commercial activity, with a consistent inflow of orders expected to positively impact our financial results throughout the year," explains Matt Boczkowski, Chief Executive Officer at Aquaporin.
"Historically, our revenue has been weighted towards the latter half of the year. Our orderbook remains robust, and we are reasserting our previously communicated financial guidance for the year," adds Klaus Juhl Wulff, Chief Financial Officer.
Financial Highlights as of March 31, 2025
Key financial metrics include:
- In the first quarter, revenue reached DKK 3.2 million, compared to DKK 6.2 million for the same period last year, primarily stemming from developments in Forward Osmosis Market.
- EBITDA before special items reported a loss of DKK 15.3 million for Q1 2025, which is an improvement from a loss of DKK 19.3 million reported in Q1 2024.
- As of March 31, 2025, cash and cash equivalents stood at DKK 58.5 million, a significant increase from DKK 2.0 million in March 2024.
- The company continues to uphold its financial outlook for 2025: anticipated revenue of DKK 60-80 million and projected EBITDA loss of DKK 45-55 million.
Q1 2025 Business Highlights
This quarter also marked significant strategic progress:
- Growing strategic accounts have led to repeat orders and a healthier diversification of revenue streams.
- Collaboration with Gallo has yielded impressive concentration quality in pilot projects.
- A strategic framework agreement was signed with Liaocheng Water Group, enhancing efforts in wastewater treatment modernization as part of a broader Sino-Danish initiative.
Post-Quarter Events
Around this timeframe, Aquaporin strengthened its international presence:
- Expansion into South and Latin American markets through VOENS orders for wastewater recycling projects in various locales.
- A pilot contract secured for delivering a Forward Osmosis system for Trinity College Dublin, contributing to innovative bioeconomy research.
- Introduction of 500 CLEAR membranes to enhance efficiency at two significant facilities in Beijing.
- Successful trials conducted in partnership with Singapore's National Water Agency demonstrating promising project outcomes.
- Notably, CEO Matt Boczkowski announced plans to step down for personal reasons but will remain until late September 2025.
Q1 2025 Commentary
In the early months of 2025, Aquaporin has registered notable advancements in both Forward and Reverse Osmosis sectors. Partnerships, especially with Gallo, showcase positive developments in product quality and position Aquaporin at the forefront of innovation within the wine industry. The query for CLEAR membranes has escalated among numerous strategic partners, solidifying the company's Industrial Water sales strategy.
Aquaporin's dedication to expanding its footprint continues to manifest in China through established ties and initiatives led by entities such as the Danish Water Alliance.
The financial results for Q1 2025 reveal a year-on-year revenue decline of DKK 3 million, yet the orderbook signals optimism for ongoing fiscal stability. Expectations remain for the bulk of revenue to accumulate in the latter part of the year, positioning Aquaporin to meet its financial objectives for 2025 with a projected EBITDA loss decline.
April marked a transitional phase as CEO Matt Boczkowski prepared to relocate, initiating the Board's search for his successor.
Contact Information
Matt Boczkowski, Chief Executive Officer
Klaus Juhl Wulff, Chief Financial Officer
+45 53 55 55 19, investorrelations@aquaporin.com
About Aquaporin
Aquaporin is a leading innovator in water technology. Headquartered in Denmark, with a global presence, the company focuses on transforming water filtration through biotechnology to address pressing water-related challenges. Utilizing its unique Aquaporin Inside® technology, developed from Nobel Prize-winning research, Aquaporin is dedicated to improving water reuse across various industries, ensuring clean water accessibility worldwide.
Frequently Asked Questions
What is the primary focus of Aquaporin's technology?
Aquaporin specializes in water filtration technology, utilizing biotechnology to create innovative solutions for water management.
How has Aquaporin performed financially in Q1 2025?
The company reported revenue of DKK 3.2 million, with a loss in EBITDA of DKK 15.3 million, showing an improvement from the previous year's figures.
What strategic agreements has Aquaporin entered into recently?
They signed a framework agreement with Liaocheng Water Group in China to advance wastewater treatment solutions as part of a Sino-Danish cooperative effort.
How does Aquaporin plan to expand its market presence?
Aquaporin is enhancing its presence in Latin America and Asia through partnerships and strategic orders aimed at sustainable water management.
What are the expectations for Aquaporin's revenue in 2025?
The Company maintains its guidance for revenue between DKK 60-80 million with a focus on late-year growth as orders materialize.
